Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/5/2019
SIETES contiene 92751 citas

 
 
 1 a 20 de 23 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Sultana J, Moretti U, Addis A, Caduff P, Capuano A, Kant A, Laporte J-R, Lindquist M, Raine J, Sartori D, Trifirò G, Tuccori M, Venegoni M, van Puijenbroek E, Leone R. Workshop on the Italian pharmacovigilance system in the international context: critical issues and perspectives. Drug Saf 2019;42:mayo. [Ref.ID 103115]
2. Cita con resumen
Viola E, Pittoni AC, Drahos A, Moretti U, Conforti A. Photosensitivity with angiotensin II receptor blockers: a retrospective study using data from VigiBase. Drug Saf 2015;38:889-94. [Ref.ID 99615]
3. Cita con resumen
Cutroneo PM, Isgrò V, Russo A, Ientile V, Sottosanti L, Pimpinella G, Conforti A, Moretti U, Caputi AP, Trifirò G. Safety profile of biological medicines as compared with non-biologicals: an analysis of the Italian spontaneous reporting system database. Drug Saf 2014;37:961-70. [Ref.ID 98406]
4. Cita con resumen
Poluzzi E, Raschi E, Koci A, Moretti U, Spina E, Behr ER, Sturkenboom M, De Ponti F. Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database. Drug Saf 2013;36:467-79. [Ref.ID 95666]
5.Enlace a cita original
Roberto G, Biagi C, Montanaro N, Koci A, Moretti U, Motola D. Statin-associated gynecomastia: evidence coming from the Italian spontaneous ADR reporting database and literature. Eur J Clin Pharmacol 2012;68:1007-11. [Ref.ID 93106]
6. Cita con resumen
Tuccori M, Lapi F, Testi A, Ruggiero E, Moretti U, Vannacci A, Bonaiuti R, Antonioli L, Fornai M, Giustarini G, Scollo C, Corona T, Ferrazin F, Sottosanti L, Blandizzi C. Drug-induced taste and smell alterations: a case/non-case evaluation on an Italian Database of spontaneous adverse drug reaction reporting. Drug Saf 2011;34:849-59. [Ref.ID 91173]
7. Cita con resumen
Velo G, Moretti U. Ecopharmacovigilance for better health. Drug Saf 2010;33:963-8. [Ref.ID 89832]
8.
Lapi F, Tucori M, Motola D, Pugi A, Vietri M, Montanaro N, Vaccheri A, Leoni O, Cocci A, Leone R, Conforti A, Moretti U, Sessa E, Mazzaglia G, Mugelli A, Mazzei T, Vannacci A. Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy. Drug Saf 2010;33:789-99. [Ref.ID 89273]
9.
Poluzzi E, Raschi E, Motola D, Moretti U, De Ponti F. Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA adverse event reporting system. Drug Saf 2010;33:303-14. [Ref.ID 88227]
10.Enlace a cita original
Piccinni C, Sacripanti C, Poluzzi E, Motola D, Magro L, Moretti U, Conforti A, Montanaro N. Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents. Eur J Clin Pharmacol 2010;66:199-206. [Ref.ID 87678]
11.Enlace a cita original
Poluzzi E, Raschi E, Moretti U, De Ponti F. Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS). Pharmacoepidemiol Drug Saf 2009;18:512-8. [Ref.ID 86355]
12. Cita con resumen
Tuccori M, Lapi F, Testi A, Coli D, Moretti U, Vannacci A, Motola D, Salvo F, Rivolta AL, Blandizzi C, Mugelli A, Del Tacca M. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous Adverse Drug Reaction Reporting. Drug Saf 2008;31:1115-23. [Ref.ID 84725]
13. Cita con resumen
Velo G, Moretti U. Direct-to-consumer information in Europe: the blurred margin between promotion and information. Br J Clin Pharmacol 2008;66:626-8. [Ref.ID 84394]
14.Tiene citas relacionadas
Moretti U, Velo G. Cosmetovigilance: the 'beautiful' risk. Drug Saf 2008;31:437-9. [Ref.ID 82911]
15. Cita con resumen
Iorio ML, Moretti U, Colcera S, Magro L, Meneghelli I, Motola D, Rivolta AL, Salvo F, Velo GP. Use and safety profile of antiepileptic drugs in Italy. Eur J Clin Pharmacol 2007;63:409-15. [Ref.ID 79821]
16. Cita con resumen
Couper M, De Carli G, Dodoo A, Edwards BD, Edwards IR, Giuliani R, Haq AS, Hartigan-Go K, Hugman B, Jones J, Leone R, Lindqvist M, Meyboom R, Moretti U, Sabatini W, Smeraldi C, Trenque T, Valdivieso L, Van Ganse E, van Grootheest K, Velo GP, Venegoni M, Vergnano M. The Erice Manifesto: For global reform of the safety of medicines in patient care. Drug Saf 2007;30:187-90. [Ref.ID 79580]
17.
Conforti A, Magro L, Moretti U, Scotto S, Motola D, Salvo F, Ros B, Leone R. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy. Drug Saf 2006;29:1163-72. [Ref.ID 78779]
18. Cita con resumen
Ibáñez L, Vidal X, Vendrell L, Moretti U, Laporte JR, on behalf of the Spanish-Italian Collaborative Group for the Epidemiology of Gastrointestinal Bleeding. Upper gastrointestinal bleeding associated with antiplatelet drugs. Aliment Pharmacol Ther 2006;23:235-42. [Ref.ID 76599]
19.
Leone R, Conforti A, Venegoni M, Motola D, Moretti U, Meneghelli I, Cocci A, Cellini GS, Scotto S, Montanaro N, Velo G. Drug-induced anaphylaxis: case/non-case study based on an Italian pharmacovigilance database. Drug Saf 2005;28:547-56. [Ref.ID 74171]
20.
Leone R, Venegoni M, Motola D, Moretti U, Piazzetta V, Cocci A, Resi D, Mozzo F, Velo G, Burzilleri L, Montanaro N, Conforti A. Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three Italian regions. Drug Saf 2003;26:109-20. [Ref.ID 64867]
Seleccionar todas
 
 1 a 20 de 23 siguiente >>